Part 212—Current Good Manufacturing Practice for Positron Emission Tomography Drugs

Subparts

• Subpart A
  Subpart A—General Provisions Sections 212.1–212.5
• Subpart B
  Subpart B—Personnel and Resources Section 212.10
• Subpart C
  Subpart C—Quality Assurance Section 212.20
• Subpart D
  Subpart D—Facilities and Equipment Section 212.30
• Subpart E
  Subpart E—Control of Components, Containers, and Closures Section 212.40
• Subpart F
  Subpart F—Production and Process Controls Section 212.50
• Subpart G
  Subpart G—Laboratory Controls Sections 212.60–212.61
• Subpart H
  Subpart H—Finished Drug Product Controls and Acceptance Sections 212.70–212.71
• Subpart I
  Subpart I—Packaging and Labeling Section 212.80
• Subpart J
  Subpart J—Distribution Section 212.90
• Subpart K
  Subpart K—Complaint Handling Section 212.100
• Subpart L
  Subpart L—Records Section 212.110